首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
【24h】

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group

机译:弥漫性固有症胶质瘤(DIPG)患者的生存效益在第一次进展中进行再辐射:代表SIOP-E-HGG / DIPG工作组的匹配队列分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Overall survival (OS) of patients with diffuse intrinsic pontine glioma (DIPG) is poor. The purpose of this study is to analyse benefit and toxicity of re-irradiation at first progression.
机译:背景:弥漫性固有猪胶质瘤(DIPG)的患者的整体存活率(OS)差。 本研究的目的是分析首次进展的再辐射的益处和毒性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号